Venkateshwara Hatcheries declares no encumbrance on Venky's shares

Venkateshwara Hatcheries Private Limited, representing the promoters and persons acting in concert of Venky's (India) Limited , declared on April 3, 2026, that no encumbrance has been created directly or indirectly on the equity shares held by them in the company. This disclosure was made to the National Stock Exchange of India Limited and BSE Limited in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The declaration confirms that the promoters and the promoter group have not pledged or charged their shareholding in Venky's (India) Limited. The submission was signed by Ketan Ranade, Company Secretary, on behalf of Venkateshwara Hatcheries Private Limited.

The filing was addressed to the stock exchanges to place the information on record. A copy of the declaration was also forwarded to the Chairman of the Audit Committee of Venky's (India) Limited.

Key Details

Detail	Description
Regulation	SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Specific Clause	Regulation 31(4)
Declaration Date	April 3, 2026
Entity	Venkateshwara Hatcheries Private Limited
Role	Promoter / Person Acting in Concert
Status	No encumbrance on equity shares

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.09%	-3.38%	-8.92%	+8.57%	-9.66%	-36.49%

Venky's (India) Limited delivered a strong financial performance for the quarter and year ended 31st March, 2026, with the Board of Directors approving the audited results at their meeting held on 14th May, 2026. The company reported a significant improvement in profitability during the quarter and the full year, driven by improved realizations and operational efficiency across its three business segments. The Board also recommended a dividend of ₹10 per equity share (100%) for the year ended 31st March, 2026, subject to shareholder approval at the ensuing Annual General Meeting. Subsequently, the company conducted an earnings call for its investors on 15th May, 2026, in relation to the financials published for the year ended 31st March, 2026. Following the call, the company filed the transcript of the conference call with the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Highlights

Revenue from operations for Q4FY26 stood at ₹1,100.47 Cr, compared to ₹843.16 Cr in Q4FY25. Profit After Tax for the quarter surged to ₹101.37 Cr from ₹13.30 Cr in the corresponding period of the previous year. For the full year FY26, the company reported a revenue of ₹3,727.32 Cr and a net profit of ₹139.25 Cr. EBITDA for Q4FY26 stood at ₹1.3B versus ₹254M in Q4FY25, with the EBITDA margin expanding significantly to 11.8% from 3.01% in the same period last year.

The following table summarises the key financial metrics for the quarter and full year:

Metric:	Q4FY26	Q3FY26	Q4FY25	FY26	FY25
Revenue from Operations (₹ Lakhs):	1,10,047	96,015	84,316	3,72,732	3,30,699
Total Income (₹ Lakhs):	1,11,620	96,998	85,504	3,77,493	3,35,117
Total Expenses (₹ Lakhs):	98,348	90,384	83,205	3,58,938	3,18,846
Profit Before Tax (₹ Lakhs):	13,272	6,614	2,299	18,555	16,271
Net Profit (₹ Lakhs):	10,137	4,858	1,330	13,925	11,662
Basic EPS (₹):	71.96	34.48	9.44	98.85	82.78

Segment Performance

All three business segments of the company registered an improvement in performance during the quarter ended 31st March, 2026. The Poultry and Poultry Products segment benefited from improved realizations from the sale of day-old chicks and grow-up birds. The Animal Health Products segment continued to post good results driven by a better product mix and focus on quality. The Oilseed segment saw a significant turnaround owing to higher capacity utilization and its ability to deliver high-quality products in a competitive environment.

The segment-wise revenue and profitability are detailed below:

Segment:	Q4FY26 Revenue (₹ Lakhs)	Q4FY25 Revenue (₹ Lakhs)	FY26 Revenue (₹ Lakhs)	FY25 Revenue (₹ Lakhs)
Poultry and Poultry Products:	55,236	47,124	1,89,675	1,92,796
Animal Health Products:	10,595	8,750	39,164	33,931
Oilseed:	47,651	30,741	1,55,414	1,14,075
Total (before inter-segment):	1,13,482	86,615	3,84,253	3,40,802

Segment:	Q4FY26 PBT (₹ Lakhs)	Q4FY25 PBT (₹ Lakhs)	FY26 PBT (₹ Lakhs)	FY25 PBT (₹ Lakhs)
Poultry and Poultry Products:	8,079	412	6,546	9,951
Animal Health Products:	3,113	1,777	9,899	7,235
Oilseed:	2,518	574	5,438	1,914
Total Segment PBT:	13,710	2,763	21,883	19,100

Balance Sheet & Cash Flow

As at 31st March, 2026, total assets stood at ₹2,30,866 lakhs, up from ₹2,07,033 lakhs as at 31st March, 2025. Total equity increased to ₹1,59,609 lakhs from ₹1,47,558 lakhs. Cash and cash equivalents at the end of the year stood at ₹6,216 lakhs, up from ₹1,488 lakhs at the beginning of the year. Net cash generated by operating activities for the year ended 31st March, 2026 was ₹19,132 lakhs, compared to ₹6,620 lakhs in the previous year.

Key balance sheet items are summarised below:

Particulars:	31 Mar 2026 (₹ Lakhs)	31 Mar 2025 (₹ Lakhs)
Total Assets:	2,30,866	2,07,033
Total Equity:	1,59,609	1,47,558
Total Non-Current Liabilities:	7,397	6,422
Total Current Liabilities:	63,860	53,053
Cash and Cash Equivalents:	6,216	1,488
Inventories:	32,901	24,788
Trade Receivables:	54,404	55,381

Dividend Declaration

The Board has recommended a dividend of ₹10 per equity share (100%) for the year ended 31st March, 2026, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The dividend, if approved by shareholders, will be paid within the statutory time limit following the ensuing Annual General Meeting.

Conference Call Transcript

Venky's (India) Limited conducted an earnings call for its investors on 15th May, 2026, in relation to the financials published for the year ended 31st March, 2026. The company has now filed the transcript of this conference call with the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted by Rohan Bhagwat, Company Secretary & Compliance Officer.